Concepedia

Tary Traore

TT

6

Publications

2.9K

Citations

6

H-Index

2009

Active since

Affiliations

Millennium Engineering and Integration (United States)(Current)

Takeda (United States)

Tary Traore is an author at Millennium Engineering and Integration (United States) specializing in drug discovery, pharmacology, and medicine.

Top concepts

Publications per year

2009–2018

6

Publications

6

An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer

Teresa A. Soucy, Peter G. Smith, Michael A. Milhollen et al. · Nature · 2009 · 2K citations

, , +9

A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment

Marc L. Hyer, Michael A. Milhollen, Jeff Ciavarri et al. · Nature Medicine · 2018 · 414 citations

, , +8

MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-κB–dependent lymphoma

Michael A. Milhollen, Tary Traore, Jennifer Adams-Duffy et al. · Blood · 2010 · 320 citations · Full text

Treatment-Emergent Mutations in NAEβ Confer Resistance to the NEDD8-Activating Enzyme Inhibitor MLN4924

Michael A. Milhollen, Michael P. Thomas, Usha Narayanan et al. · Cancer Cell · 2012 · 108 citations · Full text

, , +4

Preclinical evaluation of the selective small-molecule UBA1 inhibitor, TAK-243, in acute myeloid leukemia

Samir H. Barghout, Parasvi S. Patel, Xiaoming Wang et al. · Leukemia · 2018 · 84 citations

, , +10

Rows per page

1–5 of 6